메뉴 건너뛰기




Volumn 68, Issue 2, 2017, Pages 99-108

Lipoprotein(a) Levels in Patients with Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis

(14)  Kotani, Kazuhiko a   Sahebkar, Amirhossein b,c   Serban, Maria Corina d   Ursoniu, Sorin d   Mikhailidis, Dimitri P e   Mariscalco, Giovanni f   Jones, Steven R g   Martin, Seth g   Blaha, Michael J g   Toth, Peter P g,h   Rizzo, Manfredi i   Kostner, Karam j   Rysz, Jacek k   Banach, Maciej k  


Author keywords

abdominal aortic aneurysm; biomarker; lipoprotein(a); screening

Indexed keywords

LIPOPROTEIN A; BIOLOGICAL MARKER;

EID: 85007311106     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319716637792     Document Type: Review
Times cited : (36)

References (58)
  • 1
    • 78650845474 scopus 로고    scopus 로고
    • European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery
    • Moll F, Powell J, Fraedrich G, et al. European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2011; 41 (suppl 1): S1-S58.
    • (2011) Eur J Vasc Endovasc Surg , vol.41 , pp. S1-S58
    • Moll, F.1    Powell, J.2    Fraedrich, G.3
  • 2
    • 84921653721 scopus 로고    scopus 로고
    • Mechanisms of aortic aneurysm formation: Translating preclinical studies into clinical therapies
    • Davis FM, Rateri DL, Daugherty A,. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart. 2014; 100 (19): 1498-1505.
    • (2014) Heart , vol.100 , Issue.19 , pp. 1498-1505
    • Davis, F.M.1    Rateri, D.L.2    Daugherty, A.3
  • 3
    • 84924728298 scopus 로고    scopus 로고
    • Medical management of abdominal aortic aneurysms
    • Weiss N, Rodionov RN, Mahlmann A,. Medical management of abdominal aortic aneurysms. VASA. 2014; 43 (6): 415-421.
    • (2014) VASA , vol.43 , Issue.6 , pp. 415-421
    • Weiss, N.1    Rodionov, R.N.2    Mahlmann, A.3
  • 4
    • 84891378315 scopus 로고    scopus 로고
    • Prevalence and trends of the abdominal aortic aneurysms epidemic in general population-a meta-analysis
    • Li X, Zhao G, Zhang J, Duan Z, Xin S,. Prevalence and trends of the abdominal aortic aneurysms epidemic in general population-a meta-analysis. PloS One. 2013; 8 (12): e81260.
    • (2013) PloS One , vol.8 , Issue.12 , pp. e81260
    • Li, X.1    Zhao, G.2    Zhang, J.3    Duan, Z.4    Xin, S.5
  • 5
    • 84907954411 scopus 로고    scopus 로고
    • Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm
    • Stather P, Sidloff D, Dattani N, et al. Meta-analysis and meta-regression analysis of biomarkers for abdominal aortic aneurysm. Br J Surg. 2014; 101 (11): 1358-1372.
    • (2014) Br J Surg , vol.101 , Issue.11 , pp. 1358-1372
    • Stather, P.1    Sidloff, D.2    Dattani, N.3
  • 6
    • 70350426988 scopus 로고    scopus 로고
    • Review of current theories for abdominal aortic aneurysm pathogenesis
    • Nordon IM, Hinchliffe RJ, Holt PJ, Loftus IM, Thompson MM,. Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular. 2009; 17 (5): 253-263.
    • (2009) Vascular , vol.17 , Issue.5 , pp. 253-263
    • Nordon, I.M.1    Hinchliffe, R.J.2    Holt, P.J.3    Loftus, I.M.4    Thompson, M.M.5
  • 7
    • 84920970018 scopus 로고    scopus 로고
    • Chronic complete thrombosis of abdominal aortic aneurysm: An unusual presentation of an unusual complication
    • Pejkic S, Opacic D, Mutavdzic P, Radmili O, Krstic N, Davidovic L,. Chronic complete thrombosis of abdominal aortic aneurysm: an unusual presentation of an unusual complication. Vascular. 2015; 23 (1): 83-88.
    • (2015) Vascular , vol.23 , Issue.1 , pp. 83-88
    • Pejkic, S.1    Opacic, D.2    Mutavdzic, P.3    Radmili, O.4    Krstic, N.5    Davidovic, L.6
  • 9
    • 84896543027 scopus 로고    scopus 로고
    • Lipoprotein (a): The underestimated cardiovascular risk factor
    • Thompson GR, Seed M,. Lipoprotein (a): the underestimated cardiovascular risk factor. Heart. 2014; 100 (7): 534-535.
    • (2014) Heart , vol.100 , Issue.7 , pp. 534-535
    • Thompson, G.R.1    Seed, M.2
  • 10
    • 79954991685 scopus 로고    scopus 로고
    • Screening and therapeutic management of lipoprotein (a) excess: Review of the epidemiological evidence, guidelines and recommendations
    • Lippi G, Franchini M, Targher G,. Screening and therapeutic management of lipoprotein (a) excess: review of the epidemiological evidence, guidelines and recommendations. Clin Chim Acta. 2011; 412 (11): 797-801.
    • (2011) Clin Chim Acta , vol.412 , Issue.11 , pp. 797-801
    • Lippi, G.1    Franchini, M.2    Targher, G.3
  • 11
    • 69249099317 scopus 로고    scopus 로고
    • Circulating lipoprotein (a) concentrations and abdominal aortic aneurysm presence
    • Takagi H, Manabe H, Kawai N, Goto S, Umemoto T,. Circulating lipoprotein (a) concentrations and abdominal aortic aneurysm presence. Interact Cardiovasc Thorac Surg. 2009; 9 (3): 467-470.
    • (2009) Interact Cardiovasc Thorac Surg , vol.9 , Issue.3 , pp. 467-470
    • Takagi, H.1    Manabe, H.2    Kawai, N.3    Goto, S.4    Umemoto, T.5
  • 12
    • 69449100622 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG, Group P,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
    • (2009) BMJ , vol.339 , pp. b2535
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4    Group, P.5
  • 13
    • 0030208150 scopus 로고    scopus 로고
    • Screening study of abdominal aortic aneurysm in a general population: Lipid parameters
    • Simoni G, Gianotti A, Ardia A, Baiardi A, Galleano R, Civalleri D,. Screening study of abdominal aortic aneurysm in a general population: lipid parameters. Vascular. 1996; 4 (4): 445-448.
    • (1996) Vascular , vol.4 , Issue.4 , pp. 445-448
    • Simoni, G.1    Gianotti, A.2    Ardia, A.3    Baiardi, A.4    Galleano, R.5    Civalleri, D.6
  • 15
    • 0022921784 scopus 로고
    • Lipids, lipoproteins, and apoproteins in serum during infection
    • Alvarez C, Ramos A,. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem. 1986; 32 (1): 142-145.
    • (1986) Clin Chem , vol.32 , Issue.1 , pp. 142-145
    • Alvarez, C.1    Ramos, A.2
  • 16
    • 0023950159 scopus 로고
    • High concentrations of Lp (a) lipoprotein in serum are common among patients with abdominal aortic aneurysms
    • Norrgård O, Angquist K-A, Dahlen G,. High concentrations of Lp (a) lipoprotein in serum are common among patients with abdominal aortic aneurysms. Int Angiol. 1987; 7 (1): 46-49.
    • (1987) Int Angiol , vol.7 , Issue.1 , pp. 46-49
    • Norrgård, O.1    Angquist, K.-A.2    Dahlen, G.3
  • 17
    • 0031427440 scopus 로고    scopus 로고
    • Lipoprotein (a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm
    • Papagrigorakis E, Iliopoulos D, Asimacopoulos P, et al. Lipoprotein (a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm. Clin Genet. 1997; 52 (5): 262-271.
    • (1997) Clin Genet , vol.52 , Issue.5 , pp. 262-271
    • Papagrigorakis, E.1    Iliopoulos, D.2    Asimacopoulos, P.3
  • 18
    • 0032445605 scopus 로고    scopus 로고
    • Serum triglyceride: A possible risk factor for ruptured abdominal aortic aneurysm
    • Watt HC, Law MR, Wald NJ, Craig WY, Ledue TB, Haddow JE,. Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm. Int J Epidemiol. 1998; 27 (6): 949-952.
    • (1998) Int J Epidemiol , vol.27 , Issue.6 , pp. 949-952
    • Watt, H.C.1    Law, M.R.2    Wald, N.J.3    Craig, W.Y.4    Ledue, T.B.5    Haddow, J.E.6
  • 19
    • 19044393498 scopus 로고    scopus 로고
    • Lipoprotein (a) in patients with aortic aneurysmal disease
    • Schillinger M, Domanovits H, Ignatescu MM, et al. Lipoprotein (a) in patients with aortic aneurysmal disease. J Vasc Surg. 2002; 36 (1): 25-30.
    • (2002) J Vasc Surg , vol.36 , Issue.1 , pp. 25-30
    • Schillinger, M.1    Domanovits, H.2    Ignatescu, M.M.3
  • 20
    • 27844527994 scopus 로고    scopus 로고
    • High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm
    • Sofi F, Marcucci R, Giusti B, et al. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm. Thromb Haemost. 2005; 94 (5): 1094-1098.
    • (2005) Thromb Haemost , vol.94 , Issue.5 , pp. 1094-1098
    • Sofi, F.1    Marcucci, R.2    Giusti, B.3
  • 21
    • 34147211127 scopus 로고    scopus 로고
    • Plasma lipoprotein (a) indicates risk for 4 distinct forms of vascular disease
    • Jones GT, van Rij AM, Cole J, et al. Plasma lipoprotein (a) indicates risk for 4 distinct forms of vascular disease. Clin Chem. 2007; 53 (4): 679-685.
    • (2007) Clin Chem , vol.53 , Issue.4 , pp. 679-685
    • Jones, G.T.1    Van Rij, A.M.2    Cole, J.3
  • 22
    • 84884908791 scopus 로고    scopus 로고
    • Low-density lipoprotein receptor-related protein 5 gene polymorphisms and genetic susceptibility to abdominal aortic aneurysm
    • Galora S, Saracini C, Palombella AM, et al. Low-density lipoprotein receptor-related protein 5 gene polymorphisms and genetic susceptibility to abdominal aortic aneurysm. J Vasc Surg. 2013; 58 (4): 1062-1068.e1.
    • (2013) J Vasc Surg , vol.58 , Issue.4 , pp. 1062-1062e1
    • Galora, S.1    Saracini, C.2    Palombella, A.M.3
  • 26
    • 21544449115 scopus 로고    scopus 로고
    • Estimating the mean and variance from the median, range, and the size of a sample
    • Hozo SP, Djulbegovic B, Hozo I,. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005; 5 (1): 13.
    • (2005) BMC Med Res Methodol , vol.5 , Issue.1 , pp. 13
    • Hozo, S.P.1    Djulbegovic, B.2    Hozo, I.3
  • 27
    • 84876135427 scopus 로고    scopus 로고
    • Does PPARγ32 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis
    • Sahebkar A,. Does PPARγ32 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol. 2013; 32 (4): 188-198.
    • (2013) DNA Cell Biol , vol.32 , Issue.4 , pp. 188-198
    • Sahebkar, A.1
  • 28
    • 84899477785 scopus 로고    scopus 로고
    • Are Curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta- analysis
    • Sahebkar A,. Are Curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta- analysis. Phytother Res. 2014; 28 (5): 633-642.
    • (2014) Phytother Res , vol.28 , Issue.5 , pp. 633-642
    • Sahebkar, A.1
  • 29
    • 0033934949 scopus 로고    scopus 로고
    • Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
    • Duval S, Tweedie R,. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56 (2): 455-463.
    • (2000) Biometrics , vol.56 , Issue.2 , pp. 455-463
    • Duval, S.1    Tweedie, R.2
  • 30
    • 84878959653 scopus 로고    scopus 로고
    • MCP-1 binds to oxidized LDL and is carried by lipoprotein (a) in human plasma
    • Wiesner P, Tafelmeier M, Chittka D, et al. MCP-1 binds to oxidized LDL and is carried by lipoprotein (a) in human plasma. J Lipid Res. 2013; 54 (7): 1877-1883.
    • (2013) J Lipid Res , vol.54 , Issue.7 , pp. 1877-1883
    • Wiesner, P.1    Tafelmeier, M.2    Chittka, D.3
  • 31
    • 80054814637 scopus 로고    scopus 로고
    • Oxidized phospholipids on apoB-100-containing lipoproteins: A biomarker predicting cardiovascular disease and cardiovascular events
    • Taleb A, Witztum JL, Tsimikas S,. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med. 2011; 5 (5): 673-694.
    • (2011) Biomark Med , vol.5 , Issue.5 , pp. 673-694
    • Taleb, A.1    Witztum, J.L.2    Tsimikas, S.3
  • 32
    • 84884160203 scopus 로고    scopus 로고
    • Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
    • Leibundgut G, Scipione C, Yin H, et al. Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a). J Lipid Res. 2013; 54 (10): 2815-2830.
    • (2013) J Lipid Res , vol.54 , Issue.10 , pp. 2815-2830
    • Leibundgut, G.1    Scipione, C.2    Yin, H.3
  • 33
    • 84939543290 scopus 로고    scopus 로고
    • Circulating biomarkers and abdominal aortic aneurysm incidence: The Atherosclerosis Risk in Communities (ARIC) Study
    • Folsom AR, Yao L, Alonso A, et al. Circulating biomarkers and abdominal aortic aneurysm incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015; 132 (7): 578-585.
    • (2015) Circulation , vol.132 , Issue.7 , pp. 578-585
    • Folsom, A.R.1    Yao, L.2    Alonso, A.3
  • 34
    • 0036141412 scopus 로고    scopus 로고
    • Lipoprotein (a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo (a) transgenic rabbits
    • Ichikawa T, Unoki H, Sun H, et al. Lipoprotein (a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo (a) transgenic rabbits. Am J Pathol. 2002; 160 (1): 227-236.
    • (2002) Am J Pathol , vol.160 , Issue.1 , pp. 227-236
    • Ichikawa, T.1    Unoki, H.2    Sun, H.3
  • 35
    • 0028215089 scopus 로고
    • Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells
    • Levin EG, Miles LA, Fless GM, et al. Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells. Arterioscler Thromb Vasc Biol. 1994; 14 (3): 438-442.
    • (1994) Arterioscler Thromb Vasc Biol , vol.14 , Issue.3 , pp. 438-442
    • Levin, E.G.1    Miles, L.A.2    Fless, G.M.3
  • 36
    • 0031417438 scopus 로고    scopus 로고
    • Apolipoprotein (a) is a human vascular endothelial cell agonist: Studies on the induction in endothelial cells of monocyte chemotactic factor activity
    • Poon M, Zhang X, Dunsky K, Taubman MB, Harpel PC,. Apolipoprotein (a) is a human vascular endothelial cell agonist: studies on the induction in endothelial cells of monocyte chemotactic factor activity. Clin Genet. 1997; 52 (5): 308-313.
    • (1997) Clin Genet , vol.52 , Issue.5 , pp. 308-313
    • Poon, M.1    Zhang, X.2    Dunsky, K.3    Taubman, M.B.4    Harpel, P.C.5
  • 37
    • 84897366580 scopus 로고    scopus 로고
    • Update on lipoprotein (a) as a cardiovascular risk factor and mediator
    • Boffa MB, Koschinsky ML,. Update on lipoprotein (a) as a cardiovascular risk factor and mediator. Curr Atheroscler Rep. 2013; 15 (10): 1-10.
    • (2013) Curr Atheroscler Rep , vol.15 , Issue.10 , pp. 1-10
    • Boffa, M.B.1    Koschinsky, M.L.2
  • 38
    • 0142123357 scopus 로고    scopus 로고
    • Does lipoprotein (a) inhibit elastolysis in abdominal aortic aneurysms?
    • Petersen E, Wågberg F, Ängquist K-A,. Does lipoprotein (a) inhibit elastolysis in abdominal aortic aneurysms? Eur J Vasc Endovasc Surg. 2003; 26 (4): 423-428.
    • (2003) Eur J Vasc Endovasc Surg , vol.26 , Issue.4 , pp. 423-428
    • Petersen, E.1    Wågberg, F.2    Ängquist, K.-A.3
  • 39
    • 84945173643 scopus 로고    scopus 로고
    • Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1
    • Bown MJ, Jones GT, Harrison SC, et al. Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1. Am J Hum Genet. 2011; 89 (5): 619-627.
    • (2011) Am J Hum Genet , vol.89 , Issue.5 , pp. 619-627
    • Bown, M.J.1    Jones, G.T.2    Harrison, S.C.3
  • 40
    • 67349253521 scopus 로고    scopus 로고
    • Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm
    • Giusti B, Rossi L, Lapini I, et al. Gene expression profiling of peripheral blood in patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2009; 38 (1): 104-112.
    • (2009) Eur J Vasc Endovasc Surg , vol.38 , Issue.1 , pp. 104-112
    • Giusti, B.1    Rossi, L.2    Lapini, I.3
  • 41
    • 84880305065 scopus 로고    scopus 로고
    • A sequence variant associated with sortilin-1 (SORT1) on 1p13. 3 is independently associated with abdominal aortic aneurysm
    • Jones GT, Bown MJ, Gretarsdottir S, et al. A sequence variant associated with sortilin-1 (SORT1) on 1p13. 3 is independently associated with abdominal aortic aneurysm. Hum Mol Genet. 2013; 22 (14): 2941-2947.
    • (2013) Hum Mol Genet , vol.22 , Issue.14 , pp. 2941-2947
    • Jones, G.T.1    Bown, M.J.2    Gretarsdottir, S.3
  • 42
    • 84891514939 scopus 로고    scopus 로고
    • Interleukin-6 receptor pathways in abdominal aortic aneurysm
    • Harrison SC, Smith AJ, Jones GT, et al. Interleukin-6 receptor pathways in abdominal aortic aneurysm. Eur Heart J. 2013; 34 (48): 3707-3716.
    • (2013) Eur Heart J , vol.34 , Issue.48 , pp. 3707-3716
    • Harrison, S.C.1    Smith, A.J.2    Jones, G.T.3
  • 43
  • 44
    • 42249103284 scopus 로고    scopus 로고
    • Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts
    • Jones GT, Thompson AR, van Bockxmeer FM, et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arterioscler Thromb Vasc Biol. 2008; 28 (4): 764-770.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.4 , pp. 764-770
    • Jones, G.T.1    Thompson, A.R.2    Van Bockxmeer, F.M.3
  • 45
    • 84865125773 scopus 로고    scopus 로고
    • Apolipoprotein (a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism
    • Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Apolipoprotein (a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol. 2012; 60 (8): 722-729.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.8 , pp. 722-729
    • Helgadottir, A.1    Gretarsdottir, S.2    Thorleifsson, G.3
  • 46
    • 84923352119 scopus 로고    scopus 로고
    • SEPP1 gene variants and abdominal aortic aneurysm: Gene association in relation to metabolic risk factors and peripheral arterial disease coexistence
    • Strauss E, Oszkinis G, Staniszewski R,. SEPP1 gene variants and abdominal aortic aneurysm: gene association in relation to metabolic risk factors and peripheral arterial disease coexistence. Sci Rep. 2014; 4: 7061.
    • (2014) Sci Rep , vol.4 , pp. 7061
    • Strauss, E.1    Oszkinis, G.2    Staniszewski, R.3
  • 47
    • 80055013728 scopus 로고    scopus 로고
    • Meta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysm
    • Biros E, Norman PE, Jones GT, et al. Meta-analysis of the association between single nucleotide polymorphisms in TGF-β receptor genes and abdominal aortic aneurysm. Atherosclerosis. 2011; 219 (1): 218-223.
    • (2011) Atherosclerosis , vol.219 , Issue.1 , pp. 218-223
    • Biros, E.1    Norman, P.E.2    Jones, G.T.3
  • 48
    • 36248988019 scopus 로고    scopus 로고
    • An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms
    • Deguara J, Burnand KG, Berg J, et al. An increased frequency of the 5A allele in the promoter region of the MMP3 gene is associated with abdominal aortic aneurysms. Hum Mol Genet. 2007; 16 (24): 3002-3007.
    • (2007) Hum Mol Genet , vol.16 , Issue.24 , pp. 3002-3007
    • Deguara, J.1    Burnand, K.G.2    Berg, J.3
  • 49
    • 84890500741 scopus 로고    scopus 로고
    • When should we measure lipoprotein (a)?
    • Kostner KM, März W, Kostner GM,. When should we measure lipoprotein (a)? Eur Heart J. 2013; 34 (42): 3268-3276.
    • (2013) Eur Heart J , vol.34 , Issue.42 , pp. 3268-3276
    • Kostner, K.M.1    März, W.2    Kostner, G.M.3
  • 50
    • 84927695403 scopus 로고    scopus 로고
    • Latest developments in the treatment of lipoprotein (a)
    • Bos S, Yayha R, van Lennep JER,. Latest developments in the treatment of lipoprotein (a). Curr Opin Lipidol. 2014; 25 (6): 452-460.
    • (2014) Curr Opin Lipidol , vol.25 , Issue.6 , pp. 452-460
    • Bos, S.1    Yayha, R.2    Van Lennep, J.E.R.3
  • 51
    • 84924986048 scopus 로고    scopus 로고
    • Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: Pathophysiological aspects
    • Schmitz G, Orsó E,. Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects. Clin Res Cardiol Suppl. 2015; 10: 21-25.
    • (2015) Clin Res Cardiol Suppl , vol.10 , pp. 21-25
    • Schmitz, G.1    Orsó, E.2
  • 52
    • 84930679521 scopus 로고    scopus 로고
    • Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue
    • Yoshimura K, Nagasawa A, Kudo J, et al. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue. Int J Mol Sci. 2015; 16 (5): 11213-11228.
    • (2015) Int J Mol Sci , vol.16 , Issue.5 , pp. 11213-11228
    • Yoshimura, K.1    Nagasawa, A.2    Kudo, J.3
  • 53
    • 41949095013 scopus 로고    scopus 로고
    • Medical management of small abdominal aortic aneurysms
    • Baxter BT, Terrin MC, Dalman RL,. Medical management of small abdominal aortic aneurysms. Circulation. 2008; 117 (14): 1883-1889.
    • (2008) Circulation , vol.117 , Issue.14 , pp. 1883-1889
    • Baxter, B.T.1    Terrin, M.C.2    Dalman, R.L.3
  • 54
    • 84936995465 scopus 로고    scopus 로고
    • Tibolone decreases lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patients
    • Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group
    • Kotani K, Sahebkar A, Serban C, et al.Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Tibolone decreases lipoprotein(a) levels in postmenopausal women: a systematic review and meta-analysis of 12 studies with 1009 patients. Atherosclerosis. 2015; 242 (1): 87-96.
    • (2015) Atherosclerosis , vol.242 , Issue.1 , pp. 87-96
    • Kotani, K.1    Sahebkar, A.2    Serban, C.3
  • 55
    • 84865120887 scopus 로고    scopus 로고
    • Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: A rationale for increased efforts to understand its pathophysiology and develop targeted therapies
    • Tsimikas S, Hall JL,. Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol. 2012; 60 (8): 716-721.
    • (2012) J Am Coll Cardiol , vol.60 , Issue.8 , pp. 716-721
    • Tsimikas, S.1    Hall, J.L.2
  • 56
    • 0033634997 scopus 로고    scopus 로고
    • Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)
    • Marcovina SM, Albers JJ, Scanu AM, et al. Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem. 2000; 46 (12): 1956-1967.
    • (2000) Clin Chem , vol.46 , Issue.12 , pp. 1956-1967
    • Marcovina, S.M.1    Albers, J.J.2    Scanu, A.M.3
  • 57
    • 3242763124 scopus 로고    scopus 로고
    • First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay - Lp(a) SRM 2B
    • International Federation of Clinical Chemistry and Laboratory Medicine; IFCC Working Group for Lipoprotein(a) Assay Standardization
    • Dati F, Tate JR, Marcovina SM, Steinmetz A, International Federation of Clinical Chemistry and Laboratory Medicine; IFCC Working Group for Lipoprotein(a) Assay Standardization. First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay - Lp(a) SRM 2B. Clin Chem Lab Med. 2004; 42 (6): 670-676.
    • (2004) Clin Chem Lab Med , vol.42 , Issue.6 , pp. 670-676
    • Dati, F.1    Tate, J.R.2    Marcovina, S.M.3    Steinmetz, A.4
  • 58
    • 0034685429 scopus 로고    scopus 로고
    • Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group
    • Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283 (15): 2008-2012.
    • (2000) JAMA , vol.283 , Issue.15 , pp. 2008-2012
    • Stroup, D.F.1    Berlin, J.A.2    Morton, S.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.